Electronics Press Releases: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Electronics Press Releases.

November 2025

Mo	Tu	We	Th	Fr	Sa	Su
					1	2
3	4	5	6	7	8	9
10	11	12	13	14	15	16
17	18	19	20	21	22	23
24	25	26	27	28	29	30

December 2025

Mo	Tu	We	Th	Fr	Sa	Su
1	2	3	4	5	6	7
8	9	10	11	12	13	14
15	16	17	18	19	20	21
22	23	24	25	26	27	28
29	30	31

January 2026

Mo	Tu	We	Th	Fr	Sa	Su
			1	2	3	4
5	6	7	8	9	10	11
12	13	14	15	16	17	18
19	20	21	22	23	24	25
26	27	28	29	30	31

Press releases published on November 8, 2025

Nov. 8, 2025

Zhongshan Wiseprint Highlights CE and ROHS Certified HP Indigo-Compatible Consumables for Sustainable Label Printing

EIN Presswire

Nov. 8, 2025

Intellia Therapeutics Presents Positive Pooled Phase 1/2 Data of Lonvoguran Ziclumeran (lonvo-z) in Patients with Hereditary Angioedema

GlobeNewswire

Nov. 8, 2025

Clinical Data Demonstrating Efficacy of Sotagliflozin in Preserved Ejection Fraction Heart Failure (HFpEF) without Diabetes Presented at American Heart Association (AHA) Annual Scientific Sessions 2025

GlobeNewswire

Nov. 8, 2025

Clearwater Wellness Launches World-First Thermoelectric Ice Bath, with Tim Paine Joining as Founding Partner

GlobeNewswire

Nov. 8, 2025

Louis Limited Sets New Standard for Trading Psychology With Dynamic Emotion Tracking Features

GlobeNewswire

Nov. 8, 2025

Il SEV di ASTRAUX illumina l'EICMA 2025 e ridefinisce la mobilità urbana smart a partire da 6.590 €

GlobeNewswire

Nov. 8, 2025

Telitacicept Achieved Primary Endpoint of Reducing Proteinuria in Stage A of a Phase 3 Clinical Study for IgA Nephropathy in China

GlobeNewswire

Nov. 8, 2025

Monte Rosa Therapeutics Presents Preclinical Data at AHA Scientific Sessions 2025 on the Potential of MRT-8102, a NEK7-directed Molecular Glue Degrader, to Treat Cardiovascular and Cardiometabolic Diseases

GlobeNewswire

Nov. 8, 2025

Tenaya Therapeutics Presents Promising Interim Clinical Data from MYPEAK™-1 Phase 1b/2a Clinical Trial of TN-201 Gene Therapy for the Treatment of MYBPC3-Associated Hypertrophic Cardiomyopathy

GlobeNewswire

Nov. 8, 2025

IGEL läutet neue Ära der EUC-Transformation und vertrauenswürdigen Endpunktsicherheit ein

GlobeNewswire

Nov. 8, 2025

Judo Bio’s Megalin-STRIKERs Achieve First Demonstration of Functional Pharmacodynamic Effects from Kidney Selective Gene Silencing in Non-Human Primates

GlobeNewswire

Nov. 8, 2025

Jade Biosciences Presents New Data Demonstrating a Favorable Preclinical Safety Profile of JADE101 and a Translational Analysis of APRIL Mediated Biomarker Responses at the American Society of Nephrology Kidney Week 2025

GlobeNewswire

Nov. 8, 2025

Phase 2 Trials Demonstrating Antithrombotic Effect of Two Novel Regeneron Factor XI Antibodies Presented at American Heart Association Scientific Sessions and Published in The Lancet

GlobeNewswire

Nov. 8, 2025

Acoramidis Significantly Reduces All-cause Mortality in the Overall ATTR-CM Variant and V142I (V122I) Populations

GlobeNewswire

Nov. 8, 2025

CRISPR Therapeutics Announces Positive Phase 1 Clinical Data for CTX310® Demonstrating Deep and Durable ANGPTL3 Editing, Triglyceride and Lipid Lowering

GlobeNewswire

Nov. 8, 2025

BLUETTI Joins 11.11 Biggest Sale with Up to 74% Off on Lazada

EIN Presswire

Nov. 8, 2025

Balvionex Unveiled: How Balvionex Introduces Advanced AI for Real-Time Trading Efficiency

GlobeNewswire

Nov. 8, 2025

MemoMaster Unveiled: How This Memo Master Cutting-Edge Brain Support Supplement Is Redefining Focus and Memory Health for the Digital Era

GlobeNewswire

Nov. 8, 2025

OMS Energy, 수익성 높은 파이프라인 석유 점검 및 유지 보수 시장 진출 위해 AI+로봇 연구 개발 착수

GlobeNewswire

Nov. 8, 2025

OMSエナジー (OMS Energy)、高収益のパイプライン石油検査・保守市場への参入に向けAI+ロボティクスの研究開発を開始

GlobeNewswire